Group 1 - The medical device ETF (562600) experienced a decline of 1.70% as of the market close on October 17, 2023, despite some holdings like TransMedics, Hotgen Biotech, and Novogene showing gains of 4.45%, 2.80%, and 2.25% respectively [1] - According to the National Medical Products Administration, a total of 348 medical device products were approved for registration by September 2025, including 276 domestic Class III devices, 34 imported Class III devices, 36 imported Class II devices, and 2 devices from Hong Kong, Macau, and Taiwan [1] - CITIC Securities believes that the medical device sector, which has seen a continuous decline over the past four years, is now experiencing a rebound, with expectations for performance turning points in the second half of this year to next year due to improved procurement policies, better bidding data, and decreasing channel inventory [1] Group 2 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index, which includes 100 representative listed companies in medical devices, medical services, and medical information technology [2] - The medical device sector constitutes a significant 89.34% of the index, indicating a high concentration that allows for precise capture of the sector's growth dividends [2] - As of October 10, 2023, the top ten holdings of the medical device ETF (562600) included Mindray Medical and United Imaging Healthcare, which together accounted for 23.81% of the ETF [2]

Core Viewpoint - The medical device sector is experiencing a strong performance, with significant inflows into the medical device index ETF, indicating growing investor interest and optimism in the industry [1][2]. Market Performance - On August 11, all three major stock indices rose, with a notable performance in the growth style, particularly in the medical device sector [1]. - The medical device index ETF (159898) saw a real-time increase of 0.69% and a trading volume of nearly 20 million yuan, with a net subscription of 19 million shares during the day [1][4]. Investment Trends - The medical device index has become the most attractive pharmaceutical theme index in the A-share market over the past week, with several stocks, including SINO Medical and Nanwei Medical, experiencing significant price increases [2]. - According to CITIC Securities, the growth logic of the medical device industry is shifting from domestic substitution and penetration to internationalization and technological innovation, leading to a revaluation of the sector [2]. Company Developments - The top ten constituent stocks of the medical device index ETF include leading companies such as Mindray Medical, United Imaging, and Yuyue Medical, which represent the performance of the A-share medical device sector [3]. - The report highlights that many medical device companies are seeing high growth in their international business, which is expected to surpass domestic business in the future [2]. Future Outlook - The medical device sector is anticipated to witness a performance turning point in the second half of the year, driven by improved procurement policies, better bidding data, and decreasing channel inventory [2].